GRAXOFIL

Serial Number 87240794
606

Registration Progress

Application Filed
Nov 17, 2016
Under Examination
Jun 30, 2020
Approved for Publication
May 16, 2017
Published for Opposition
May 16, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: GRAXOFIL
Previous Owner: Accord Biopharma, Inc.
Classes: 005

Trademark Image

GRAXOFIL

Basic Information

Serial Number
87240794
Filing Date
November 17, 2016
Published for Opposition
May 16, 2017
Abandonment Date
August 2, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 2, 2021
Classes
005

Rights Holder

Accord Biopharma, Inc.

03
Address
1009 Slater Road, Suite 210
Durham, NC 27703

Ownership History

Apotex Technologies Inc.

Original Applicant
03
Toronto, Ontario CA

Apotex Technologies Inc.

Owner at Publication
03
Toronto, Ontario CA

Accord Biopharma, Inc.

New Owner After Publication #1
03
Durham, NC

Legal Representation

Attorney
Sheryl L. De Luca

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

33 events
Date Code Type Description Documents
Aug 2, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 2, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 15, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 14, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 30, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 14, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 29, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 29, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 29, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 29, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 30, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 16, 2020 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
May 16, 2020 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
May 16, 2020 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Apr 15, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 18, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 3, 2019 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 10, 2017 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jun 14, 2017 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
May 16, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 16, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 26, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 7, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 3, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 3, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 3, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 28, 2017 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Feb 28, 2017 GPRA F PRIORITY ACTION E-MAILED Loading...
Feb 28, 2017 CPRA R PRIORITY ACTION WRITTEN Loading...
Feb 23, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 23, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biosimilar pharmaceutical preparation, namely, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia

Classification

International Classes
005